Background The case involves a patent dispute between Pfizer Inc. and its subsidiaries (FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., and Wyeth LLC) (Petitioners) against Softgel Healthcare Private Limited (Respondent), an Indian Company. The dispute centres around the alleged infringement of Pfizer’s “441 Patent” related to TAFAMIDIS 61 mg capsules, sold under the brand name…
C.A.(COMM.IPD-PAT) 4/2025, I.A. 3780/2025 & I.A. 3781/2025 Delhi High Court The appellants through this Appeal before the Delhi High Court sought to overturn a decision by the Assistant Controller of Patents and Designs refusing their patent application, titled “Innovative Change To Solve Any Dispute, Unexpected Business Loss, Closures, Financial Loss, Unexpected Accidents,”. The application was…
We were delighted to be part of the 14th Annual Pharma IPR India Conference in Mumbai, where discussions around biologics and the evolving landscape of the Indian pharmaceutical industry took center stage. Suvarna Pandey, Associate Partner from our team participated in the conference. India, often referred to as the “pharmacy of the world,” plays a…
In a significant ruling, the Bombay High Court has set aside the Trade Marks Registry’s refusal Order to register the device mark consisting of Prakriti Paint with cow head device logo under Class 2. The Court held that the Registrar of Trade Marks erred in applying Section 9(1)(b) of the Trade Marks Act, 1999, which…
